PUBLICATION REGISTRY

Go to research.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för KN-93. Visa hela publikationsregistret

A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publications in the selection

15 hits

Bibliografisk träff 2015-10-14

KN-93 inhibits IKr in mammalian cardiomyocytes.

Hegyi B, Chen-Izu Y, Jian Z, Shimkunas R, Izu LT, Banyasz T.

J Mol Cell Cardiol · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1016/j.yjmcc.2015.10.012

Bibliografisk träff 2015-05-27

Apoptosis induced by NAD depletion is inhibited by KN-93 in a CaMKII-independent manner.

Takeuchi M, Yamamoto T.

Exp Cell Res · research support, non-u.s. gov't; journal article · DOI 10.1016/j.yexcr.2015.05.019

Bibliografisk träff 2015-04-29

Intrathecal injection of KN93 attenuates paradoxical remifentanil-induced postoperative hyperalgesia by inhibiting spinal CaMKII phosphorylation in rats.

Jiang M, Zhang W, Cheng C, Ma Z, Gu X.

Pharmacol Biochem Behav · research support, non-u.s. gov't; journal article · DOI 10.1016/j.pbb.2015.04.015

Bibliografisk träff 2014-12-10

CaMKII inhibition with KN93 attenuates endothelin and serotonin receptor-mediated vasoconstriction and prevents subarachnoid hemorrhage-induced deficits in sensorimotor function.

Edvinsson L, Povlsen GK, Ahnstedt H, Waldsee R.

J Neuroinflammation · research support, non-u.s. gov't; research-article; journal article · DOI 10.1186/s12974-014-0207-2

Bibliografisk träff 2014-05-15

KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3⁺ regulatory T cells in MRL/lpr mice.

Koga T, Mizui M, Yoshida N, Otomo K, Lieberman LA, Crispín JC, Tsokos GC.

Autoimmunity · research-article; journal article; research support, n.i.h., extramural · DOI 10.3109/08916934.2014.915954

Bibliografisk träff 2014-05-14

The inhibitor of calcium/calmodulin-dependent protein kinase II KN93 attenuates bone cancer pain via inhibition of KIF17/NR2B trafficking in mice.

Liu Y, Liang Y, Hou B, Liu M, Yang X, Liu C, Zhang J, Zhang W, Ma Z, Gu X.

Pharmacol Biochem Behav · research support, non-u.s. gov't; journal article · DOI 10.1016/j.pbb.2014.05.003

Bibliografisk träff 2013-10-20

KN-93, A CaMKII inhibitor, suppresses ventricular arrhythmia induced by LQT2 without decreasing TDR.

Wang WL, Zhang SS, Deng J, Zhao JY, Zhao CQ, Lin L, Zhang CT, Lv JG.

J Huazhong Univ Sci Technolog Med Sci · journal article · DOI 10.1007/s11596-013-1172-1

Bibliografisk träff 2013-08-19

Intrastriatal injections of KN-93 ameliorates levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Yang X, Wu N, Song L, Liu Z.

Neuropsychiatr Dis Treat · research-article; journal article · DOI 10.2147/ndt.s45422

Bibliografisk träff 2013-01-01

The calmodulin-dependent protein kinase II inhibitor KN-93 protects rat cerebral cortical neurons from N-methyl-D-aspartic acid-induced injury.

Liu X, Ma C, Xing R, Zhang W, Tian B, Li X, Li Q, Zhang Y.

Neural Regen Res · research-article; journal article · DOI 10.3969/j.issn.1673-5374.2013.02.002

Bibliografisk träff 2012-02-20

Novel protein kinase signaling systems regulating lifespan identified by small molecule library screening using Drosophila.

Spindler SR, Li R, Dhahbi JM, Yamakawa A, Sauer F.

PLoS One · research support, non-u.s. gov't; research-article; journal article · DOI 10.1371/journal.pone.0029782

Bibliografisk träff 2007-03-01

KN-93, a specific inhibitor of CaMKII inhibits human hepatic stellate cell proliferation in vitro.

An P, Zhu JY, Yang Y, Lv P, Tian YH, Chen MK, Chen MK, Luo HS.

World J Gastroenterol · research-article; journal article · DOI 10.3748/wjg.v13.i9.1445

Bibliografisk träff 2005-12-20

KN-93 (2-[N-(2-hydroxyethyl)]-N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine), a calcium/calmodulin-dependent protein kinase II inhibitor, is a direct extracellular blocker of voltage-gated potassium channels.

Rezazadeh S, Claydon TW, Fedida D.

J Pharmacol Exp Ther · research support, non-u.s. gov't; journal article · DOI 10.1124/jpet.105.097618

Bibliografisk träff 2000-03-01

Inhibition of CaM kinase II activation and force maintenance by KN-93 in arterial smooth muscle.

Rokolya A, Singer HA.

Am J Physiol Cell Physiol · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1152/ajpcell.2000.278.3.c537

Bibliografisk träff 1998-12-01

KN-93, an inhibitor of multifunctional Ca++/calmodulin-dependent protein kinase, decreases early afterdepolarizations in rabbit heart.

Anderson ME, Braun AP, Wu Y, Lu T, Wu Y, Schulman H, Sung RJ.

J Pharmacol Exp Ther · research support, u.s. gov't, p.h.s.; research support, non-u.s. gov't; journal article · DOI 10.1016/s0022-3565(24)37893-0

Bibliografisk träff 1991-12-01

The newly synthesized selective Ca2+/calmodulin dependent protein kinase II inhibitor KN-93 reduces dopamine contents in PC12h cells.

Sumi M, Kiuchi K, Ishikawa T, Ishii A, Hagiwara M, Nagatsu T, Hidaka H.

Biochem Biophys Res Commun · journal article · DOI 10.1016/0006-291x(91)92031-e